View on Pubmed.gov 37452431 | View on doi.org 10.1186/s13195-...
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer's disease.
- Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Department of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
- Department of Neurology, Shanghai No. 9 People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China.
- Affiliated Hospital of Jining Medical University, Jining, 272000, Shandong, China. jyfyxp@126.com.
- Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. hdguo@shutcm.edu.cn.
- Department of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. hdguo@shutcm.edu.cn.
- Department of Neurology, Shanghai No. 9 People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China. gh_cui@qq.com.
Abstract
Alzheimer's disease (AD) is a common age-related neurodegenerative disease in the central nervous system and is the primary cause of dementia. It is clinically characterized by the memory impairment, aphasia, apraxia, agnosia, visuospatial and executive dysfunction, behavioral changes, and so on. Incidence of this disease was bound up with age, genetic factors, cardiovascular and cerebrovascular dysfunction, and other basic diseases, but the exact etiology has not been clarified. MicroRNAs (miRNAs) are small endogenous non-coding RNAs that were involved in the regulation of post-transcriptional gene expression. miRNAs have been extensively studied as noninvasive potential biomarkers for disease due to their relative stability in bodily fluids. In addition, they play a significant role in the physiological and pathological processes of various neurological disorders, including stroke, AD, and Parkinson's disease. MiR-155, as an important pro-inflammatory mediator of neuroinflammation, was reported to participate in the progression of β-amyloid peptide and tau via regulating immunity and inflammation. In this review, we put emphasis on the effects of miR-155 on AD and explore the underlying biological mechanisms which could provide a novel approach for diagnosis and treatment of AD.
References
Med Sci (Paris). 2018 Nov;34(11):922-924
J Allergy Clin Immunol. 2018 Apr;141(4):1202-1207
J Clin Med. 2021 Apr 21;10(9):
Mol Neurodegener. 2018 Oct 12;13(1):54
Cited by 10 citations (total)
Journal Article Review Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't
The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases.
Electronic publication date November 27, 2024
Mousumi Ghosh [...] Damien D Pearse et al.
Microglia, the resident immune cells of the central nervous system (CNS), play a crucial role in maintaining neural homeostasis but...
Journal Article Review
Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease.
Electronic publication date January 12, 2024
Xun Zhou [...] Wei Zhao et al.
Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide and has a high incidence in the elderly. Unfortunately, there...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
Substances
- •
- •
Copyright
© 2023. The Author(s).